RecruitingNCT03193970

Measuring Surgical Recovery After Radical Cystectomy

Sponsor

M.D. Anderson Cancer Center

Enrollment

2,000 participants

Start Date

Apr 30, 2015

Study Type

OBSERVATIONAL

Conditions

Bladder Cancer

Summary

The intent of this study is to establish a registry of post-surgical outcomes in patients undergoing radical cystectomy at MD Anderson Cancer Center and the collaborating institutions. The goals of this initiative are to obtain a detailed baseline of multiple patient-reported outcomes (PRO) and clinician-reported outcomes (CRO) as well as various presenting conditions associated with them, so that future quality improvement interventions can be evaluated accurately as to their relative contribution to improved outcomes.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is measuring how quickly and completely patients recover from radical cystectomy — a major surgery to remove the bladder, usually done to treat bladder cancer — and identifying factors that affect recovery speed and quality of life after the operation. **You may be eligible if...** - You have bladder cancer and are scheduled to undergo radical cystectomy (full bladder removal surgery) at MD Anderson Cancer Center or a partner hospital **You may NOT be eligible if...** - There are no formal exclusion criteria listed — all bladder cancer patients undergoing this surgery at participating centres may be considered Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPost-Operative Recovery Registry

Multi-institutional prospective database of patients with bladder cancer undergoing radical cystectomy.

Locations(11)

University of California - San Francisco

San Francisco, California, United States

Stanford University

Stanford, California, United States

Emory University

Atlanta, Georgia, United States

University of Chicago

Chicago, Illinois, United States

University of Kansas Medical Center

Lawrence, Kansas, United States

John Hopkins Medical Institutions

Baltimore, Maryland, United States

Spectrum Health Medical Group

Grand Rapids, Michigan, United States

Winthrop University Hospital

Mineola, New York, United States

University of Rochester

Rochester, New York, United States

University of Texas - Southwestern

Dallas, Texas, United States

University of Texas MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03193970

Related Trials

DESTINY-PANTUMOUR04

NCT0712400017 locations

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

NCT000268841 location

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

NCT0741929521 locations

En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device

NCT042357641 location

Bladder Cancer Screening Trial

NCT056464851 location